BETA: Please send your feedback!
Corcept Therapeutics
CORT:NAS
Pharmaceuticals: Other
$0
SMALL cap
$12.88
(-0.48%)
-0.10%
since start of 2019
16.99
- —
- 1
- 2
- 3
- 4
- 5
About
Pharmaceuticals: Other
Founded 1998
Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| Joseph K. Belanoff, MD | President, Chief Executive Officer, Director & MD | Male |
| Robert S. Fishman, MD | Chief Medical Officer | Male |
| Susan P. Rinne | Vice President-Corporate Regulatory Affairs | Female |
| David B. Singer, MBA | Founder | Male |
| James N. Wilson, MBA | Chairman | Male |
| Gary Charles Robb | Secretary & Chief Financial Officer | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
Corcept Therapeutics - Competitors and Related Companies
How Corcept Therapeutics stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.
Corcept Therapeutics
CORT:NAS
Pharmaceuticals: Other
$0
SMALL cap
$12.88
(-0.48%)
-0.10%
since start of 2019
16.99
Impax Laboratories
IPXL:NAS
Pharmaceuticals: Generic
—
SMALL cap
(—)
—
since start of 2019
—
MannKind
MNKD:NAS
Biotechnology
$278.65mm
SMALL cap
$1.35
(-0.05%)
0.11%
since start of 2019
-5.24
Catalyst Biosciences
CBIO:NAS
Biotechnology
$59.24mm
MICRO cap
$4.92
(-0.05%)
-0.41%
since start of 2019
-1.12
Johnson & Johnson
JNJ:NYS
Pharmaceuticals: Major
$372.09bn
MEGA cap
$141.38
(0.04%)
0.11%
since start of 2019
26.64
Novartis
NOVN-CH:SWX
Pharmaceuticals: Major
$58.77mm
MEGA cap
$2.20
(0.04%)
1.26%
since start of 2019
-2.18